Arkolith/Insider Trading/SCTX/Form 4

AH Bio Fund II, L.P.

10% OwnerScribe Therapeutics, Inc. (SCTX) · full profile →Form 4 · filed Jul 29, 2026
Net Buying
Open-Market Buys
$5.0M
Open-Market Sells
$0
Net Open-Market Flow
$5.0M
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 27, 2026Conversion(C)2.1M——2.1M
Jul 27, 2026Conversion(C)698K——698K
Jul 27, 2026Buy(P)333K$15.00$5.0M2.4M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 27, 2026Conversion(C)12.2M—$00
Jul 27, 2026Conversion(C)4.1M—$00

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-26-000813) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML